Brevail White Paper

The Brevail white paper is a scientific research monograph, a distillation of all current research regarding the potential applications for lignans in the preservation of healthy breast tissue.

Study Quotations

There is a great deal of scientific and medical interest in the potential health applications of lignans. Provided herein are quotations selected from studies published in peer-reviewed medical journals reporting on these promising compounds.

Physiologic Actions

According to research scientists writing in The Journal of Progressive Drug Research, lignans have now been shown to influence not only sex-hormone metabolism and biological activity but also intracellular enzymes, protein synthesis, growth factor action, malignant cell proliferation, differentiation and angiogenesis, making them strong candidates as natural cancer chemo-preventative compounds.

Research Reports

Reported in the prestigious medical journal, The Lancet, high urinary excretion of lignan is associated with a substantial reduction in breast-cancer risk.

Brevail Research Grants

Brevail was awarded an unprecedented, two consecutive, research grants in the course of the 6-year span in which Brevail was researched and developed.

Brevail Oral Pharmacokinetic Study

Brevail was the subject of two university-based pharmacokinetic studies designed to determine the optimal oral dose of Brevail in women.

Brevail Biomedical Advisory Board

Leading Scientists, Medical Doctors and Healthcare Practitioners serve to keep Brevail at the forefront of medical and nutritional science.